UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By BOPA on 12th May 2022

REGISTRATION NOW OPEN – The 25th Annual BOPA Symposium, 7-9 October, Liverpool

An important date for your diaries: The 25th British Oncology Pharmacy Association (BOPA) Annual Symposium (7th – 9th October). Oncology and haematology are ever-changing landscapes and this year we are looking to…

Read article
By BOPA Committee on 11th May 2022

Vote for the 2023 Symposium Venue: PAID members

The BOPA committee are giving all PAID members of BOPA the opportunity to help inform the choice of venue for the 2023 BOPA symposium. If you wish to take part…

Read article
By BOPA Committee on 11th May 2022

PUBLIC CONSULTATION NOW OPEN ** Draft International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) **

The ADDIKD draft guideline is open for public consultation until midnight (AEST) 31st May 2022.  The BOPA Committee would appreciate your input with this process. The Draft Guideline can be…

Read article
By BOPA Committee on 10th May 2022

BOPA Executive Committee TCON Minutes – March 2022

Please see the minutes for all the BOPA Executive TCON meetings HERE

Read article

25th BOPA Symposium 2022

7th to 9th October 2022 at The ACC Liverpool

Non members: Contact Media1Productions: [email protected]
Please see Key information before for accommodation information.

Please click here to view the latest agenda.

Early-bird rate applies up until Monday 22nd August 2022

Everything you need to know